◀ Back to PRKAG2
PRKAG2 — SRC
Text-mined interactions from Literome
Liu et al., Cell cycle (Georgetown, Tex.) 2009
(Breast Neoplasms) :
At the molecular level, metformin increases
P-AMPK ,
reduces P-EGFR, EGFR, P-MAPK,
P-Src , cyclin D1 and cyclin E ( but not cyclin A or B, p27 or p21 ), and induces PARP cleavage in a dose- and time dependent manner
Lee et al., J Biol Chem 2012
:
Metformin also increased phosphorylation of
Src in an
AMPK dependent manner